Quadrant Capital Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Quadrant Capital Group's LMAT Position: Q2 2026 in Review
Quadrant Capital Group reduced its LeMaitre Vascular (LMAT) stake by 0.35% in Q2 2026, selling an estimated $1.54K and leaving 4,330 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #956.
Quadrant Capital Group first reported a position in LMAT in Q1 2020 and has held it in 26 quarters since. The position peaked at $474K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Quadrant Capital Group held 4,330 shares of LeMaitre Vascular worth $416K as of Q2 2026.
- Quadrant Capital Group sold 15 LeMaitre Vascular shares in Q2 2026, an estimated $1.54K.
- LeMaitre Vascular made up 0.01% of Quadrant Capital Group's portfolio in Q2 2026, its #956 holding.
- Quadrant Capital Group first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 26 quarters since.
- Quadrant Capital Group's LeMaitre Vascular position peaked at $474K in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.